Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROle of Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic Shock: Randomized Controlled Trial (RODIS Trial)

NCT03989609 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT03989609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03989609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROle of Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic Shock: Randomized Controlled Trial (RODIS Trial)
Lead sponsor
Kasr El Aini Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 20, 2019
Completion date
August 20, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock